Stocklytics Platform
Asset logo for symbol RCKT
Rocket Pharmaceuticals
Asset logo for symbol RCKT



AI Deep-Learning Forecast (RCKT)

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Rocket Pharmaceuticals (RCKT) Stocklytics Forecast

Rocket Pharmaceuticals Inc (RCKT) is a biotechnology company that focuses on the development and commercialization of gene therapies for rare diseases. The company's innovative approach utilizes lentiviral vectors to deliver therapeutic genes to target cells in the body. With a mission to provide potentially life-changing treatments for patients, Rocket Pharmaceuticals has gained attention in the medical community and among investors.

When it comes to the stock price prediction for Rocket Pharmaceuticals Inc, it is important to consider various factors that can influence the market. While it is impossible to predict the future with certainty, analysts and experts closely monitor the company's performance, pipeline, and market trends to forecast potential outcomes.

add Rocket Pharmaceuticals  to watchlist

Keep an eye on Rocket Pharmaceuticals

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

What is the analyst price prediction for Rocket Pharmaceuticals (RCKT) stock?

Analysts have set a target price of $52.65 for Rocket Pharmaceuticals (RCKT), based on forecasts from 26 analysts. The predicted price range extends from a high of $65 to a low of $33. This represents a potential increase of up to 188.89% and a decrease of 46.67% from the current price of $22.5. These forecasts are as of 2022 Nov 07.

What are the analyst ratings for Rocket Pharmaceuticals (RCKT) stock?

Currently, there are no analyst ratings available for Rocket Pharmaceuticals (RCKT), possibly due to insufficient coverage or recent updates.

What is the AI price prediction for Rocket Pharmaceuticals (RCKT) stock?

At present, there is no AI or machine-learning-based price prediction available for Rocket Pharmaceuticals (RCKT) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.


Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level